Kinetics of innate immune response to Yersinia pestis after intradermal infection in a mouse model

Infection and Immunity

Volumn 80, Issue 11, 2012, Pages 4034-4045

  Bosio, Christopher F ^a   Jarrett, Clayton O ^a   Gardner, Donald ^a   Hinnebusch, B Joseph ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHATE BUFFERED SALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL LOAD; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; INNATE IMMUNITY; KINETICS; LEUKOCYTE ACTIVATION; LYMPH NODE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; OTITIS; PLAGUE; PRIORITY JOURNAL; YERSINIA PESTIS;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRADERMAL; MICE; MICE, INBRED BALB C; NEUTROPHIL INFILTRATION; NEUTROPHILS; PLAGUE; SURVIVAL ANALYSIS; YERSINIA PESTIS;

EID: 84867619240     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00606-12     Document Type: Article

References (54)

1. Autenrieth IB, Tingle A, Reske-Kunz A, Heesemann J. 1992. T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica. Infect. Immun. 60:1140-1149.
2. Autenrieth SE, et al. 2010. Immune evasion by Yersinia enterocolitica: differential targeting of dendritic cell populations in vivo. PLoS Pathog. 6:e1001212. doi:10.1371/journal.ppat.1001212.
3. Belkaid Y, Jouin H, Milon G. 1996. A method to recover, enumerate and identify lymphomyeloid cells present in an inflammatory dermal site: a study in laboratory mice. J. Immunol. Methods 199:5-25.
4. Bergsbaken T, Cookson BT. 2009. Innate immune response during Yersinia infection: critical modulation of cell death mechanisms through phagocyte activation. J. Leukoc. Biol. 86:1153-1158.
5. Boland A, Cornelis GR. 1998. Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection. Infect. Immun. 66:1878-1884.
6. Brubaker RR. 1991. Factors promoting acute and chronic diseases caused by yersiniae. Clin. Microbiol. Rev. 4:309-324.
7. Brubaker RR. 2003. Interleukin-10 and the inhibition of innate immunity to yersiniae: roles of Yops and LcrV (Vantigen). Infect. Immun. 71:3673-3681.
8. Bubeck SS, Cantwell AM, Dube PH. 2007. Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice. Infect. Immun. 75:697-705.
9. Cavanaugh DC, Randall R. 1959. The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague. J. Immunol. 83:348-363.
10. Chen TH, Foster LE, Meyer KF. 1961. Experimental comparison of the immunogenicity of antigens in the residue of ultrasonated avirulent Pasteurella pestis with the vaccine prepared with the killed virulent whole organisms. J. Immunol. 87:64-71.
11. Comer JE, et al. 2010. Transcriptomic and innate immune responses to Yersinia pestis in the lymph node during bubonic plague. Infect. Immun. 78:5086-5098.
12. Condliffe AM, Chilvers ER, Haslett C, Dransfield I. 1996. Priming differentially regulates neutrophil adhesion molecule expression/ function. Immunology 89:105-111.
13. Cornelis GR. 2002. Yersinia type III secretion: send in the effectors. J. Cell Biol. 158:401-408.
14. Davey MS, et al. 2011. Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog. 7:e1002040. doi:10.1371/journal.ppat.1002040.
15. Engelthayer DM, Hinnebusch BJ, Rittner CM, Gage KL. 2000. Quantitative competitive PCR as a technique for exploring flea-Yersinia pestis dynamics. Am. J. Trop. Med. Hyg. 62:552-560.
16. Erfurth SE, et al. 2004. Yersinia enterocolitica induces apoptosis and inhibits surface molecule expression and cytokine production in murine dendritic cells. Infect. Immun. 72:7045-7054.
17. Gage KL, Kosoy MY. 2005. Natural history of plague: perspectives from more than a century of research. Annu. Rev. Entomol. 50:505-528.
18. Guinet F, Avé P, Jones L, Huerre M, Carniel E. 2008. Defective innate cell response and lymph node infiltration specify Yersinia pestis infection. PLoS One 3:e1688. doi:10.1371/journal.pone.0001688.
19. Hudson BW, Feingold BF, Kartman L. 1960. Allergy to flea bites. I. Experimental induction of flea-bite sensitivity in guinea pigs. Exp. Parasitol. 9:18-24.
20. Inglesby TV, et al. 2000. Plague as a biological weapon: medical and public health management: Working Group on Civilian Biodefense. JAMA 283:2281-2290.
21. Jones SM, Day F, Stagg A, Williamson E. 2000. Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains. Vaccine 19:358-366.
22. Kawahara K, Tsukano H, Watanabe H, Lindner B, Matsuura M. 2002. Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect. Immun. 70:4092-4098.
23. Kerschen EJ, Cohen DA, Kaplan AM, Straley SC. 2004. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect. Immun. 72:4589-4602.
24. Kindt TJ, Goldsby RA, Osborne BA. 2007. Cells and organs of the immune system, p 23-51. In Kuby immunology, 6th ed. WH Freeman, New York, NY.
25. Knirel YA, et al. 2005. Temperature-dependent variations and intraspecies diversity of the structure of the lipopolysaccharide of Yersinia pestis. Biochemistry 44:1731-1743.
26. Kuuliala K, Orpana A, Leirisalo-Repo M, Repo H. 2007. Neutrophils of healthy subjects with a history of reactive arthritis show enhanced responsiveness, as defined by CD11b expression in adherent and non-adherent whole blood cultures. Rheumatology 46:934-937.
27. Kylänpää-Bäck M-L, et al. 2001. Cellular markers of systemic inflammation and immune suppression in patients with organ failure due to severe acute pancreatitus. Scan. J. Gastroenterol. 10:1100-1107.
28. Larsen CP, et al. 1990. Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 172:1483-1493.
29. Lathem WW, Crosby SD, Miller VL, Goldman WE. 2005. Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proc. Natl. Acad. Sci. U. S. A. 102:17786-17791.
30. Lee SE, Johnstone IP, Lee RP, Opdebeeck JP. 1999. Putative salivary antigens of the cat flea, Ctenocephalides felis felis. Vet. Immunol. Immunopathol. 69:229-237.
31. Lemaître N, Sebbane F, Long D, Hinnebusch BJ. 2006. Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in lymph node but is not required for virulence in a rat model of bubonic plague. Infect. Immun. 74:5126-5131.
32. Lorange EA, Race BL, Sebbane F, Hinnebusch BJ. 2005. Poor vector competence of fleas and the evolution of hypervirulence in Yersinia pestis. J. Infect. Dis. 191:1907-1912.
33. McDonald B, et al. 2010. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330:362-366.
34. Montminy SW, et al. 2006. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nature Immunol. 7:1066-1073.
35. Moore F, Jr. 2004. Complement, p 97-100. In Pier GB, Lyczak JB (ed), Immunology, infection, and immunity. ASM Press, Washington, DC.
36. Motin VL, et al. 2004. Temporal global changes in gene expression during temperature transition in Yersinia pestis. J. Bacteriol. 186:6298-6305.
37. Nakajima R, Brubaker RR. 1993. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect. Immun. 61:23-31.
38. Nakajima R, Motin VL, Brubaker RR. 1995. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect. Immun. 63:3021-3029.
39. Navarro L, Alto NM, Dixon JE. 2005. Functions of the Yersinia effector proteins in inhibiting host immune responses. Curr. Opin. Microbiol. 8:21-27.
40. Nedialkov YA, Motin VL, Brubaker RR. 1997. Resistance to lipopolysaccharide mediated by the Yersina pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infect. Immun. 65:1196-1203.
41. Perry RD, Fetherston JD. 1997. Yersinia pestis: etiologic agent of plague. Clin. Microbiol. Rev. 10:35-66.
42. Price PA, Jin J, Goldman WE. 2012. Pulmonary infection by Yersinia pestis rapidly establishes a permissive environment for microbial proliferation. Proc. Natl. Acad. Sci. U. S. A. 109:3083-3088.
43. Pujol C, Bliska JB. 2005. Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae. Clin. Immunol. 114:216-226.
44. Robinson RT, et al. 2008. Yersinia pestis evades TLR4-dependent induction of IL-12(p40)2 by dendritic cells and subsequent cell migration. J. Immunol. 181:5560-5567.
45. Sánchez-Margalet V, et al. 2004. Expression of activation molecules in neutrophils, monocytes and lymphocytes from patients with unstable angina treated with stent implantation. Clin. Chem. Lab. Med. 42:273-278.
46. Sebbane F, Gardner D, Long D, Gowen BB, Hinnebusch BJ. 2005. Kinetics of disease progression and host response in a rat model of bubonic plague. Am. J. Pathol. 166:1427-1439.
47. Sebbane F, Jarrett CO, Gardner D, Long D, Hinnebusch BJ. 2006. Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc. Natl. Acad. Sci. U. S. A. 103:5526-5530.
48. Spinner JL, Cundiff JA, Kobayashi SD. 2008. Yersinia pestis type III secretion system-dependent inhibition of human polymorphonuclear leukocyte function. Infect. Immun. 76:3754-3760.
49. -Yersinia pestis in BALB/c mice. Infect. Immun. 57:1200-1210.
50. Van den Broeck W, Derore A, Simoens P. 2006. Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J. Immunol. Methods 312:12-19.
51. Viboud GI, Bliska JB. 2005. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59: 69-89.
52. Welkos S, Friendlander A, McDowell D, Weeks J, Tobery S. 1998. V antigen of Yersinia pestis inhibits neutrophil chemotaxis. Microb. Pathog. 24:185-196.
53. Zhao L, et al. 2006. A rodent model for allergic dermatitis induced by flea antigens. Vet. Immunol. Immunopathol. 114:285-296.
54. Zhou X, et al. 2005. LPS activation of Toll-like receptor 4 signals CD11b/ CD18 expression in neutrophils. Am. J. Physiol. Lung Cell. Mol. Physiol. 288:L655-L662.